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ABSTRACT
The pathophysiology of allergic asthma is driven by Th2
immune responses after aeroallergen inhalation. The
mechanisms that initiate, potentiate, and regulate airway
allergy are incompletely characterized. We have shown
that Hh signaling to T cells, via downstreamGli transcription
factors, enhances T cell conversion to a Th2 phenotype. In
this study, we showed for the first time, to our knowledge,
that Gli-dependent transcription is activated in T cells in vivo
during murine AAD, a model for the immunopathology of
asthma, and that genetic repression of Gli signaling in
T cells decreases the differentiation and recruitment of Th2
cells to the lung. T cells were not the only cells that
expressed activated Gli during AAD. A substantial pro-
portion of eosinophils and lung epithelial cells, both central
mediators of the immunopathology of asthma, also un-
derwent Hh/Gli signaling. Finally, Shh increased Il-4 ex-
pression in eosinophils. We therefore propose that Hh
signaling during AAD is complex, involving multiple cell
types, signaling in an auto- or paracrine fashion. Improved
understanding of the role of this major morphogenetic
pathway in asthma may give rise to new drug targets for
this chronic condition. J. Leukoc. Biol. 102: 000–000;2017.
Introduction
Asthma is a complex, heterogeneous respiratory disease character-
ized by airway inﬂammation, hyperresponsiveness, obstruction, and
remodeling. For many, asthma is a chronic, life-long condition
controlled by inhaled corticosteroids, leukotriene antagonists, and
short- or long-acting bronchodilators. Approximately 3 people per
day die as a result of asthma in the UK alone (Asthma UK Data
Portal and Ofﬁce for National Statistics, London, UK). Asthma
can be subdivided into a series of variable phenotypes,
categorized by the prominent cellular inﬁltrates and patho-
physiology observed in the airway [1]. Most asthma episodes
are thought to be triggered by allergens (allergic asthma) and
are characterized by eosinophilia and Th2 immune responses.
Allergic conditions are linked to epithelial barrier dysfunc-
tion, which potentiates immune responses to allergens,
although the mechanisms behind this are not clear [2].
Allergic asthma results from misguided immune reaction to
aeroallergens, the most common of which are derived from HDMs
[3]. Sensitization is complex and is dependent on a series of genetic
and environmental factors, including extent of aeroallergen
exposure, predisposition to atopy, composition of personal micro-
biota, exposure to pollutants and time spent indoors in early life [4].
Aeroallergens are ingested by mucosal APCs and presented to
T cells in local LNs. T cell activation and conversion to a Th2
phenotype triggers the production of IgE, subsequent activation of
mast cells, eosinophils and the production of inﬂammatory
mediators. Persistent allergen exposure, sustained immune in-
ﬁltration, and chronic inﬂammation result in excessive mucus
production, smooth muscle contraction, airway remodeling, and
hyperresponsiveness, leading to the symptoms of asthma.
The mechanisms driving Th2 conversion and persistence in
response to inhaled allergens are incompletely characterized.
The heterogeneity of asthma phenotypes, disease course, and
treatment response implies that there are many factors that
synergize to determine phenotype and increase overall risk of
disease and treatment failure. It is therefore important to dissect
the molecular mechanisms that contribute to the induction and
persistence of Th2 immune pathology.
We have shown that Hh signaling to T cells potentiates
differentiation of naive T cells to a Th2 phenotype and that Shh
1. Correspondence: School of Life Sciences, University of Bedfordshire, Park
Square, Luton, LU1 3JU, UK. E-mail: anna.furmanski@beds.ac.uk
This is an Open Access article distributed under the terms of the Creative
Commons Attribution 4.0 International (CC BY 4.0) (http://creativecommons.
org/licenses/by/4.0/) which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Abbreviations: AAD = allergic airways disease, BAL = bronchoalveolar lavage,
Dhh =Desert hedgehog, EMT = epithelial tomesenchymal transition, Gli = glioma-
associated oncogene, GliA = transcriptional activator Gli, GliR = transcriptional
repressor Gli, GWAS = genome-wide association studies, HDM = house dust
mite, Hh = Hedgehog, Hhip = Hedgehog interacting protein, Ihh = Indian
hedgehog, LN = lymph node, PAS = Periodic Acid Schiff, Ptch = patched, Shh =
Sonic Hedgehog, Smo = smoothened, SNP = single-nucleotide polymorphism
The online version of this paper, found at www.jleukbio.org, includes
supplemental information.
0741-5400/17/0102-0001 © The Author(s) Volume 102, July 2017 Journal of Leukocyte Biology 1
 Epub ahead of print March 24, 2017 - doi:10.1189/jlb.3HI1016-438RR
 Copyright 2017 by The Society for Leukocyte Biology. Vol.,  No. , pp:, June, 2017Journal of Leukocyte Biology. 128.41.35.169 to IP www.jleukbio.orgDownloaded from 
ligand is upregulated in the airway of mice with allergic airway
disease, a murine model of asthma pathophysiology [5]. This
work indicates that Shh is one such factor that can contribute to
Th2-mediated responses. The relationship between Shh signal-
ing and allergic asthma has not been explored in detail to date.
Hh proteins are intercellular signaling molecules that are vital for
patterning during embryogenesis but also play several roles after
birth in tissue homeostasis [6]. There are 3 mammalian Hh
proteins: Shh, Dhh, and Ihh, all of which share a common signaling
pathway. Upon ligand binding to the Hh receptor Ptch, signal
transduction is initiated by derepression of Smo, which triggers an
intracellular signaling cascade culminating in the activation of Gli
transcription factors. Gli-dependent transcription of target genes is
driven by the abundance of GliA relative to transcriptional GliR in
the cell. Gli1 acts as an activator of transcription, Gli2 as an activator
and repressor, and Gli3 predominantly as a transcriptional repressor
[7]. Target genes of Gli are wide ranging and cell-context
dependent. We have shown that in mature CD4+ T cells, Gli target
genes include Hh signaling molecules: Ptch1 [8], Smo [5]; Th2-
modulators: Il-4, Il-1rl1 [5]; and genes linked to allergic disease:
Tgfb3 [9], Igf1r [10], and Csf2 [11].
Several genes related to the Hh signaling pathway have been
linked to asthma. Large GWASs have implicated HHIP [12],
PTCHD1 [13], and PTCHD3 [14] in poorer asthmatic lung
function. Gene expression analyses comparing Th2-high and
Th2-low asthma phenotypes found differences in expression of
Dhh and Disp1 between groups [15]. These ﬁndings have been
predominantly discussed in the context of developmental
biology, with the authors suggesting that the Hh pathway may be
linked to lung function as a consequence of its role in lung
branching morphogenesis.
We have shown that Hh signaling via Gli-dependent transcription
potentiates the conversion of naive T cells to Th2 effectors by
upregulation of Th2-related genes including the key cytokine IL-4
[5]. We therefore propose that the linkage between Hh signaling
and asthma may be due to the inﬂuence of Hh on Th2 immune
responses in addition to any structure–function effects driven by
differences in morphogen signaling during lung development and
postnatally in lung tissue homeostasis. In this study, we investigated
the relationship between Hh/Gli signaling and allergic immune
responses in vivo using murine models of asthma pathology.
MATERIALS AND METHODS
Mice, tissues, and cells
Lck-Gli2DC2 (C2, Gli2R [8]), GFP-Gli reporter mice (Gli binding site-GFP
transgenic, GBS-GFP Tg [16]), and littermate/age-matched controls, all
C57BL/6 background, and C57BL/6 and BALB/c WT mice were bred and
maintained at UCL under UK Home Ofﬁce regulations. AAD was induced as
described [5]. HDM allergen was given 3 times per week for the number of
weeks stated in the ﬁgures. BAL, lung lobes, and draining LNs were harvested.
Lung tissue was cryopreserved for sectioning or homogenization or minced
and digested with 1.5 mg/ml Liberase (Roche Diagnostics, Burgess Hill, UK)
and 0.5 mg/ml DNAse (Roche Diagnostics), subjected to erythrocyte lysis and
prepared for ﬂow cytometry, or subjected to lysis for RNA extraction. To
obtain SiglecF+ cells (eosinophils), cells were puriﬁed from pooled BALB/c
lung and spleen leukocytes by streptavidin-based magnetic bead positive
selection (Thermo Fisher Scientiﬁc, Waltham, MA, USA) using anti-SiglecF-
biotin (Miltenyi, Bergisch-Gladbach, Germany). Cells were then cultured at
2.5 3 105/ml in AIM V medium (Thermo Fisher Scientiﬁc) for 24 h in the
presence or absence of 500 ng/ml recombinant Shh (R&D Systems,
Minneapolis, MN, USA) before lysis for RNA extraction.
Flow cytometry and cell sorting
Samples were stained with antibodies from Thermo Fisher Scientiﬁc, acquired on
a C6 Accuri ﬂow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and
analyzed using FlowJo v10 (Tree Star, Ashland, OR, USA). For cell sorting,
samples were acquired on a MoFlo XDP or FACSDiva (Beckman Coulter, Brea,
CA, USA) and deﬁned as follows: epithelium, CD45-Epcam+; endothelium, CD45-
Epcam-CD31+; eosinophils, SiglecF+CD11b+; neutrophils, CD11b+Ly6G(IA8)hi;
and alveolar macrophages, CD11bloCD11c+; CD4+ T cells, CD4+CD11c2.
qPCR
qPCR was performed in triplicate for at least 2 independent experiments with
Quantitect primers (Qiagen, Valencia, CA, USA) on a Rotor-Gene thermal
cycler (Qiagen) or an iCycler (Bio-Rad, Hercules, CA, USA). Data were
normalized to Hprt expression and are represented as relative mean
expression 6 SD of independent experiments, the number of data points
indicating the number of mice or samples analyzed.
Immunoﬂuorescence
Immunoﬂuorescence was performed on fresh frozen acetone-ﬁxed 5 mm
sections of OCT-embedded lung tissue. All antibodies were from Thermo
Fisher Scientiﬁc, unless otherwise stated. To detect Shh: goat anti-Shh clone
N19 (Santa Cruz Biotechnology, Dallas, TX, USA), followed by donkey anti-
goat biotin (Alpha Diagnostic International, San Antonio, TX, USA) and
streptavidin-Alexa Fluor 555 or anti-biotin Alexa Fluor 488; E-cadherin: anti-
E-cadherin followed by anti-rat IgG1 PE; SiglecF: anti-mouse SiglecF and
anti-rat IgG2a eFluor570; CD16: anti-mouse CD16/32 followed by anti-rat
IgG2a eFluor570; CD45: anti-mouse CD45.2-FITC; and CD31: anti-mouse
CD31-APC. Data were captured on a BX63 epiﬂuorescence microscope
(Olympus, Tokyo, Japan) or an LSM 710 confocal microscope (Zeiss, Jena,
Germany) and analyzed using cellSens (Olympus) and Image J (National
Institutes of Health, Bethesda, MD, USA) software. Magniﬁcations are given
as power of microscope objective; where multiple magniﬁcations are used in
a single ﬁgure, scale bars are also included.
Lung histology
Lung lobes were formalin-ﬁxed, parafﬁn-embedded samples. Sections (5 mm)
were subjected to PAS staining with hematoxylin counterstaining, assessed by
a blinded observer, and scored for cellular inﬁltration and PAS+ mucus
production. Scores denote inﬁltration and mucus production as 0–1, minimal;
1–2, moderate; and 2–3, severe.
Data analysis
Statistical analyses were performed with Microsoft Excel or Prism 4 (Graph
Pad, San Diego, CA, USA). Two-tailed unpaired Student’s t tests were used to
assess statistical signiﬁcance, which was accepted at P , 0.05. All data are
represented as means 6 SEM, with the exception of qPCR data, which are
displayed as stated above.
RESULTS AND DISCUSSION
Shh expression increases in lung during AAD induction
by allergen administration
We have shown that Shh signals to T cells to favor a Th2 immune
response and that Shh protein is increased in the lung tissue of
mice after 3 wk of allergen dosing [5]. To further understand
when and where Hh ligand is expressed during AAD induction,
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we examined the expression of Shh in lung during a time
course of allergen administration. BALB/c mice were given 3
doses of HDM allergen per week for 0, 1, 2, 3 or 5 wk. A
progressive induction of a classic Th2 immune response was
observed, including the appearance of CD4+T1ST2+ (Th2) cells
in BAL (Supplemental Fig. S1A), lung (Supplemental Fig. S1B)
and eosinophilia (Supplemental Fig. S1C). Concurrently, we
observed a progressive increase in Shh mRNA (Supplemental
Fig. S1D) and protein (Supplemental Fig. S1E) in lung tissue.
Shh colocalized with E-cadherin+ airway epithelia (Supplemen-
tal Fig. S1F), supporting our published observations. Further, as
early as 1 wk into the AAD time course we also observed Shh
expression around pulmonary vessels (v) and in areas of cellular
inﬁltration (i) around bronchi/bronchioles (Supplemental Fig.
S1F). Shh colocalized with a subset of peribronchiolar CD45+
cells (Supplemental Fig. S1G), indicating that in addition to
epithelia, cells of hematopoietic origin express Shh during AAD.
We therefore show that there are several potential cellular sources
of Shh, some of which are recruited to the disease site during AAD.
Lymphocytes respond to Gli-activating signals in vivo
during AAD
To directly test our hypothesis that lymphocytes receive Hh/Gli-
activating signals in vivo during AAD [5], we performed a time-
course allergen dosing experiment on GFP-Gli reporter mice [16]
and WT (non-GFP) littermates. GFP-Gli+ mice are engineered to
express GFP in cells that have received an activating signal
upstream of the Gli transcription factors. GFP expression inside
cells reﬂects the presence of GliA and therefore activation of Gli-
dependent transcription. To ensure that the reporter did not have
any background effect on our experiments, we compared AAD
immune parameters in GFP-Gli+ and GFP-Gli2 littermates. Across
a 5 wk AAD time course, there were no differences in immune cell
recruitment between the 2 genotypes, indicating that the presence
of the reporter construct does not itself have any inﬂuence on
AAD progression (Fig. 1A).
Using GFP-Gli+ mice, we then examined expression of GFP
in lymphocytes and CD4+ cells during an AAD time-course.
GFP+CD4+ cells were observed in draining LNs after only 1 wk
of allergen dosing, with a further increase at 3 wk (Fig. 1B, C).
GFP+ cells were also evident in BAL (Fig. 1D, E) and lung (Fig.
1F, G), indicating that lymphocytes undergo Gli-dependent
transcription during AAD. Upon allergen inhalation, the number
of GFP+CD4+ cells increased in LNs, particularly in BAL, which
represents a major site of immune reactivity at the interface
between the epithelium and the airspaces. These data suggest
that there is a subset of T cells in vivo that are able to respond to
Hh or other Gli-activating signals and that these cells increase in
number during AAD. Our previous work suggested that such
cells would potentiate a Th2 response [5]. We therefore
hypothesized that repression of Gli activity in T cells would limit a
Th2 response in vivo and dampen allergic pathology.
Repression of Gli activity in T cells impairs the
recruitment of CD4+ and Th2 cells during AAD
To test the effect of repressing Gli activity in T cells on AAD, we
induced disease in transgenic mice that overexpress the repressor
form of Gli2 (Gli2R) under the control of the Lck promoter (C2,
Lck-Gli2R). Gli-dependent transcription was therefore repressed
in these mice in T cells only: C2 T cells do not efﬁciently
upregulate Gli target genes compared to WT T cells, upon receipt
of an Hh signal [8]. C2 and WT littermates were given PBS or
HDM allergen for 3 wk and the T cell phenotype was examined. As
predicted, signiﬁcantly fewer CD4+T1ST2+ Th2 cells were
recruited to the lungs (Fig. 2A) and LNs (Fig. 2B) of C2 vs. WT
mice during AAD. This result indicates a speciﬁc effect of Gli2
repression on the differentiation and recruitment of CD4+ Th2
cells during AAD. It is particularly noteworthy that C2 tissues
contain fewer CD4+T1ST2+ cells during AAD because these
transgenic mice show enhanced selection of CD4+ single-positive
cells in the thymus and an increased proportion and enhanced
signaling, activation, and proliferation potential of CD4+ cells in
peripheral lymphoid tissues [8, 17].
We noted a signiﬁcant decrease in the presence of neutrophils
in the lung and BAL of C2 mice after allergen administration
(Fig 2C). This ﬁnding implies that the repression of Gli activity in
T cells has a secondary effect on the recruitment, activation, or
differentiation of neutrophils in response to HDM inhalation.
There was a comparable number of neutrophils in lung and BAL
in the PBS-treated C2 and WT groups (Fig 2C), suggesting that
neutrophil development is not impaired in C2 mice. It therefore
seems plausible that the presence of GliR in T cells alters the
production of a factor that controls neutrophil proliferation,
mobilization or chemotaxis to the lung in response to in-
ﬂammation or danger. Of interest, C2 CD4+ T cells express lower
levels of Csf2 transcript than WT [5]; this gene encodes GM-CSF,
a key cytokine for neutrophil recruitment and activation [18].
However, when we measured AAD pathology in the lungs of
C2 and WT mice, we noted no signiﬁcant differences between
the 2 genotypes. Despite the decrease in the number of Th2 cells,
eosinophilia was not signiﬁcantly different (Fig. 2D), PAS
staining revealed comparable mucus production, and histologic
examination of lung inﬁltration suggested that overall, AAD
pathology was not diminished in the lungs (Fig. 2E, F). Th2-
related cytokines in whole-lung homogenates were equivalently
induced by HDM treatment in WT and C2 groups (Fig. 2G),
despite the fact that the T1ST2+ population was reduced in C2
mice. This result suggests that other cells are responsible for most
IL-4, -5, and -13 in lung. Indeed, Th2 cells are not the only source
of these cytokines: among other cells, eosinophils, recruited in
large numbers during AAD, also produce IL-4, -5, and -13 [19].
We therefore considered the possibility that there are other, as
yet uncharacterized cells in the lung that respond to Shh during
AAD and inﬂuence Th2 responses.
Innate immune cells and lung epithelium respond to
Gli-activating signals in vivo
To assess whether other cells involved in AAD respond to Hh/Gli
signaling, we screened for GFP expression and thus GliA during
an AAD time course in GFP-Gli+ reporter mice. We examined
sections of lung lobes to determine the location of GFP+ cells.
We found no GFP expression in GFP-Gli2 littermate lung
samples (Fig. 3A), but GFP was highly expressed around lung
structures including bronchial/bronchiolar and alveolar epithelium
and diffusely throughout other areas of the lung during AAD in
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GFP-Gli+ lungs (Fig. 3B). We noted variable and graded expression
of GFP throughout the tissue, implying that some cells expressed
higher levels of Gli than others. This ﬁnding is consistent with the
graded signaling that would be expected with a morphogen and is
detectable with this reporter, which has been used to model the
dynamics of morphogen signaling in neural development [16]. It is
currently unknown to what extent morphogen gradients function in
adult tissue. Hh signaling in adult lung has promoted pro mitogenic
[20, 21] and antiproliferative [22] effects in models of acute lung
injury. These conﬂicting results could be related to differences in
experimental models or may reﬂect functional differences in
morphogen gradients in tissues.
Coimmunoﬂuorescence analyses showed that GFP signal was
strongest in E-cadherin+ bronchial cells and in peribronchial
cells after 3 wk allergen inhalation, particularly at the air
interface (Fig. 3C). Weaker GFP signal (seen on merged images
as pink-yellow, depending on the strength of the GFP signal)
also colocalized with a subset of peribronchial SiglecFhi
cells—possibly the eosinophils about to egress into the airspaces
(and therefore BAL)—after HDM dosing (Fig. 3D). Colocalization
of GFP was also observed with some CD16+ cells; thus, we also
detected Gli activity in a subset of phagocytic cells (Fig. 3E). We
did not detect GFP expression in CD31+ cells at 3 wk (Fig. 3F),
indicating that pulmonary endothelium does not express active
Figure 1. Lymphocytes respond to Hh signaling in vivo during AAD. GFP-Gli reporter mice (GFP-Gli+, GFP+) and WT (GFP-Gli2, GFP2) littermates
(n = 3 per group) underwent repeated intranasal challenge with PBS or 25 mg HDM allergen in PBS. Mean 6 SEM cell count in BAL, leukocytes in
LNs, and lung digests (A) , in GFP-Gli+ groups (B, C) GFP status of CD4+ cells in LNs (numbers indicate percentage of positive cells). Mean 6 SEM
number of GFP+ lymphocytes (D) and CD4+ cells (E) in BAL (F) and lung (G), respectively. *P # 0.05; **P # 0.005, compared to the control
group at t = 0 wks.
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Figure 2. Repression of Gli activation in T cells lowers Th2-cell recruitment and neutrophilia in AAD. C2 (Gli2R) and WT littermates (n = 5 or 6 per
group) underwent intranasal challenge with PBS or 25 mg HDM allergen in PBS, receiving 9 doses over 3 wk. Flow cytometric analysis of the mean 6 SEM number of
CD4+T1ST2+ Th2 cells in lung digests (A) and in LNs (B), percentage of CD11bhiLy6G(IA8)+CD11c-SiglecF- neutrophils in live lung and BAL leukocyte gates (C), and
number of eosinophils in BAL and lung (D). (E) PAS and hematoxylin staining of formalin-ﬁxed, parafﬁn-embedded lung sections. Asterisks: highly cellular immune
inﬁltrates. Representative examples are shown; magniﬁcation 320. (F) operator-blinded scoring of cellular inﬁltration and mucus production in PAS/hematoxylin
sections: 0–1, minimal; 1–2, moderate; and 2–3, severe. (G) ELISA analysis of cytokine concentration in whole-lung homogenates. *P # 0.05; **P # 0.005.
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Gli in AAD at this time point. These data indicate that lung
epithelial cells, some eosinophils, and phagocytes are all subject to
Hh/Gli signaling during AAD.
We also quantiﬁed cells expressing GliA by ﬂow cytometry in
whole lung homogenates and in BAL. At 3 wk most of the
eosinophils in BAL expressed GFP (Fig. 4A), as did a lower but
still substantial proportion of neutrophils (Fig. 4B). GFP
expression was sustained in these cells into wk 5 of allergen
dosing (Fig. 4C). GFP expression was also observed in a
proportion of lung eosinophils (Fig. 4D, E), in a minority of
lung neutrophils and a subset of lung macrophages (Fig. 4F).
These data indicate that innate immune cells, in particular a
signiﬁcant subset of eosinophils, are capable of responding to
Hh or other Gli-activating signals during allergen inhalation.
Figure 3. GFP-Gli is expressed in epithelial cells
and subsets of innate leukocytes. GFP expression
in GFP-Gli- control (A) and in GFP-Gli+ (B) lung
cryosections. Immunoﬂuorescence of GFP-Gli+
lung cryosections after 3 wk allergen inhalation
following costaining with anti-E-cadherin(C), anti-
SiglecF (D), anti-CD16 (E), and anti-CD31(F).
Colocalization in red/green merged images ap-
pears as yellow or paler pink, depending on the
intensity of the green ﬂuorescence.
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To our knowledge, this has never been reported. We noted a
much higher frequency of GFP+ eosinophils in BAL and lung
digests when we analyzed samples from our AAD experiments
by ﬂow cytometry (Fig. 4), compared with immunoﬂuores-
cence (Fig. 3). This effect may be caused by the enhanced
sensitivity of cytometry or by cytometric gating strategies, and
lung cryosections, which are extensively washed during
staining, may simply not mimic the cellular content of intact
whole-lung digests. Alternatively, it may represent a real
difference in Gli activation. BAL contains eosinophils that
have egressed from pulmonary tissue, which may well have
received Hh signals when passing through the epithelial
barrier. Lung and BAL eosinophils are also functionally
distinct during AAD, with inﬂammatory eosinophils located in
BAL and peribronchial areas and regulatory eosinophils found
largely in lung parenchyma [23]. The function of eosinophils can
thus be heavily inﬂuenced by their location in tissue, presumably
via responses to local microenvironmental signals; we propose that
Shh/Gli signaling is one such local signal, active during allergic
responses.
Lung epithelium, endothelium, and innate immune
cells, particularly eosinophils, express key molecules of
the Hh signaling pathway
To conﬁrm that lung tissue and innate immune cells express
the machinery required for Hh/Gli signaling, we sorted
epithelial and endothelial cells, eosinophils, neutrophils,
macrophages, and CD4+ T cells from lung digests of WT mice
and performed qPCR to assess gene expression. In control
mice, epithelial cells expressed Shh (as in ref. 5), Ihh, Hhip,
Ptch, Smo, and Gli1 indicating potential to both produce Hh
ligand and receive Hh signals (Fig. 5A). Endothelial cells
expressed negligible levels of Shh but did express Hh signaling
machinery. Upon HDM inhalation, epithelial cells expressed
all of the genes listed above. Compared with epithelial cells,
endothelial cells expressed slightly higher levels of Hhip, Ptch,
Smo, and Gli1 (Fig. 5B). These results indicate that the Hh
signaling capacity in the endothelial cells of the pulmonary
vasculature may change from their baseline state after allergen
exposure.
The respiratory epithelium is an important physical barrier
and immune organ, increasingly linked to the initiation and
maintenance of unwanted allergic immune responses. HDM
allergens including Derp1 protease disrupt epithelial tight
junctions [24], permitting transepithelial passage of allergen
and immune priming. Derp1 also stimulates the release of
proinﬂammatory cytokines from respiratory epithelium [25],
which are important in subsequent immune skewing. We show,
for the ﬁrst time to our knowledge, that lung epithelia also
express Hh signaling machinery during AAD, suggesting that
auto- and paracrine Hh signaling is possible in this compart-
ment after allergen inhalation. Embryogenic morphogens such
as Shh are re-expressed in adult lung to maintain epithelial
and mesenchymal cell quiescence [22]. Dysregulation of this
signaling is strongly implicated in pulmonary ﬁbrosis in mouse
models [20] and humans [26]. It is plausible that Shh signaling
in epithelial cells contributes to the long-term ﬁbrotic airway
remodeling seen in chronic asthma. Hh signaling regulates the
EMT during lung development and branching morphogenesis.
Asthma has been proposed as a disorder of dysregulated EMT,
although this theory is controversial. Nevertheless, morpho-
genetic pathways appear to be good candidates for driving
EMT during lung disease, including asthma (reviewed in
ref. 27).
Naive (Fig. 5C) and allergen-exposed (Fig. 5D) eosinophils
expressed Ptch and Smo Hh receptor and signal-transduction
molecules, respectively, and Gli1 at higher levels than any of
the other innate immune cells and, indeed, higher than CD4+
T cells. Naive eosinophils also expressed Hh ligands, Shh
and Dhh, and Hhip (Fig. 5C). These cells are recruited in
abundance to BAL (hundreds of thousands) and lung
(millions) during the induction of AAD (Supplemental Fig.
S1C) and thus are likely to be a major source of Hh ligand.
After allergen treatment, Ihh expression was unexpectedly
induced in eosinophils (Fig. 5D). There is little literature on
this response, although Ihh has a role in thymocyte develop-
ment [28] and macrophage polarization [29]. It is important
to fully characterize this and the role of Hh signaling in other
innate immune cells before Hh inhibitors are investigated as a
potential treatment for Th2-mediated disease. Neutrophils and
macrophages from HDM-exposed mice expressed the Hh
signal-transduction molecules Ptch and Smo, but at lower levels
than expressed by eosinophils (Fig. 5D). As in baseline
conditions (Fig. 5C), neutrophils continued to express Hh
ligands. As neutrophil recruitment and/or activation is
affected by repression of Gli-dependent transcription in T cells
(Fig. 2C), and neutrophils are Gli responsive (Fig. 4), it would
be interesting to examine the role of Hh/Gli signaling in
neutrophilic/Th17 asthma. Macrophages expressed Shh and
Ihh, but not Dhh, after HDM inhalation (Fig. 5D). Shh/Gli
ligand expression and signaling have been reported in
macrophages/monocytes [29–31]. There is evidence that
macrophages upregulate both Shh and Ihh after exposure to
schistosome antigens, and that this effect can lead to M2
polarization and a subsequent proﬁbrotic environment in the
liver [29]. It remains to be seen whether Hh signaling in lung
during AAD favors M2 differentiation and pulmonary ﬁbrosis
or airway remodeling.
HHIP is expressed in adult lung tissue including the lung
epithelium, pulmonary endothelium, and eosinophils (Fig. 5).
Several GWASs have repeatedly identiﬁed SNPs at the HHIP
locus, the endogenous inhibitor of Hedgehog ligands, to affect
lung function [32–34] and to predispose to increased suscep-
tibility to asthma [12]. Patients with chronic obstructive
pulmonary disease have decreased HHIP mRNA and protein
expression [35]. Functionally, two of the associated SNPs have
been shown to be within an HHIP enhancer region that
interacts with the HHIP promotor, and both SNPs reduce
promotor activity [35]. Altered HHIP levels may well lead to
enhanced Shh signaling, and we speculate consequent similar
corollaries as we have reported here.
Shh activates Gli-dependent transcription via the canonical
pathway. We have established that the components of the
canonical hedgehog pathway are present in lung tissue and
immune cells. However, we also acknowledge that Hh ligand can
signal noncanonically and that Gli-dependent transcription can
Standing et al. Hh/Gli Signaling in allergic airways disease
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Figure 4. Innate immune cells express can respond to Hh/Gli signals during AAD in vivo. GFP-Gli reporter mice (n = 3 in each group) underwent
repeated intranasal challenge with 25 mg HDM allergen in PBS as described. Flow cytometry was used to analyze eosinophils (A) and neutrophils
(B) in BAL. Representative ﬂow proﬁles are shown at 3 wk; numbers indicate percentage of eosinophils, bold numbers indicate percentage of live
gate. (C) Percentage and number per ml BAL of GFP+ eosinophils and neutrophils, (D) %GFP+ in lung CD4+ T cell populations and number of
GFP+ lung (E) eosinophils, (F) neutrophils and macrophages. *P # 0.05; **P # 0.005, compared to the control group at t = 0 wks.
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Figure 5. Innate immune cells, particularly eosinophils, express key molecules of the Hh signaling pathway. Lungs were harvested from C57BL/6
(A, B; n = 3 per group) or BALB/c WT (C, D; n = 2 per group) allergen-naive (A, C) or HDM-treated (B, D) mice and lung epithelial and
endothelial (A, B) or resident (C, D) lung eosinophils, neutrophils, macrophages, and CD4+ T cells were sorted by FACS and subjected to gene
expression analysis by qPCR. Expression of Shh, Hhip, Ptch, Smo, Gli1, Ihh, and Dhh are expressed relative to Hprt in each cell subset, data points
represent individual mice. (E) SiglecF+ cells were separated from WT mice (n = 2 independent experiments) and cultured for 24 h in the presence
(+Shh) or absence (control) of 500 ng/ml recombinant mouse Shh protein. Expression of Il-4 in the treated group was assessed by qPCR in
triplicate, relative to the control samples.
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be triggered by non-Hh ligands, such as TGF-b [36]. The
crosstalk of these signaling pathways in AAD and asthma
therefore warrants further investigation.
Eosinophils, recruited to lung and BAL in a high
number in AAD, can respond to Hh signals by
upregulating transcription of Il-4
Our data suggest that eosinophils, key cells in the Th2
response, produce Hh ligands and respond to Hh signals. To
directly test the effect of Shh signaling to eosinophils, we
puriﬁed SiglecF+ cells from murine lung and spleen and
cultured the cells in the presence or absence of recombinant
mouse Shh. As in CD4+ T cells [5], Shh treatment triggered
upregulation of Il-4 in eosinophils (Fig. 5E). This ﬁnding
suggests that Hh ligands, produced by various lung cell types
during AAD can further potentiate Th2 cytokine production,
and it could explain why repression of Gli activity in T cells
only (Lck-Gli2R transgenic) did not signiﬁcantly alter total IL-4
concentration in AAD lung tissue (Fig. 2C). However, the
Smo inhibitor cyclopamine promotes eosinophilic differenti-
ation of leukemic myeloid cells [37]; thus, it is currently
unclear what role Hh signaling plays in eosinophil differen-
tiation and function.
Our initial model proposing that Shh is released from lung
epithelial cells after allergen inhalation therefore requires
modiﬁcation to include CD45+ innate leukocytes such as
eosinophils and neutrophils (Fig. 6). The model should also
be extended to reﬂect the Hh/Gli signaling potential of
eosinophils, CD16+, and epithelial cell subsets, and the
inﬂuence of Shh on Il-4 transcription in eosinophils, poten-
tially exacerbating the local Th2 response. The full conse-
quences of Gli activation in each of the cell types examined in
this study are currently unknown. In addition to its roles in
maintaining quiescence and tissue homeostasis, postnatal re-
expression of Shh in lung may therefore also have evolved as a
beneﬁcial Th2-potentiating mechanism to protect against lung
parasites. Of note, Shh production is increased in astrocytes of
mice infected with Angiostrongylus cantonensis, the rat lung-
worm [38]. However, in allergy, excess Shh in lung tissue is
potentially pathologic, and it may exacerbate Th2-driven
disease. This possibility requires further investigation to fully
characterize the role of Hh signaling in the allergic lung,
which is clearly complex. Of further interest are group 2
innate lymphoid cells, which lack antigen receptors but are
early producers of Th2 cytokines in immune responses. These
cells are particularly important in driving Th2 responses in the
papain-induced AAD model [39]. Their development is regulated
by the morphogenic pathways NOTCH and Wnt/b-catenin
(reviewed in ref. 40); thus, it is important to establish whether
there is a role for Hh/Gli signaling in the differentiation and
function of this cell type.
In summary, this study reports a novel role for Hh signaling
in the crosstalk between pulmonary cells and inﬁltrating
leukocytes during the induction of an allergic immune
response. Future work should determine the role of canonical
and noncanonical Hh/Gli signaling in eosinophils, neutro-
phils, and airway epithelia in the presence and absence of
allergens. The Hh/Gli signaling pathway is complex and
subject to several regulatory and feedback mechanisms. It
will be very interesting to dissect the kinetics of Hh/Gli
signaling in these cell types during AAD. It is not currently
clear in which cell type, if any, Hh signaling is absolutely
required for AAD induction. It may well be the case that Hh
signaling is another pathway that contributes to, rather than
controls, disease pathogenesis. Together, this information
should uncover novel biologic mechanisms and allow the
rational design of potential modulators of Th2-driven lung
disease.
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Figure 6. Multiple cell types in lung produce and respond to Shh,
potentiating Th2 responses as a consequence of allergen inhalation in
AAD. Our working model [5] has been updated to incorporate our
new ﬁndings. We propose that in addition to triggering allergic
immune responses via CD4+ Th2 activation, HDM allergen also
induces the release of Shh in lung (HDM action). Shh is the
primary Hh ligand secreted in the lung during AAD (Shh ligand,
black circles) and that the source cells include epithelia, eosino-
phils, and other CD45+ leukocytes (Shh release, white arrows).
T cells are able to respond to Shh (Shh/Gli response, black arrows),
leading to Gli activation and upregulation of genes involved in Th2
skewing, leading to the potentiation of Th2 pathology and further
inﬂammation/injury, potentially further increasing Shh expression.
Epithelial cells and some CD16+ cells express active Gli (black
dashed arrows), likely in response to Shh, but the outcome of the
signal to these cell types is currently unknown. Eosinophils also
express activated Gli, and one consequence of this via Shh signaling
is the upregulation of IL4, which may further drive Th2 activation
and disease.
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